Please assess the completion status of the following clinical trial:

Trial Title: Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chronological age greater than 28 days~* Gestational age at birth less than 32 weeks and 6 days~* Diagnosis of BPD (supplemental oxygen requirement for greater than or equal to 28 days)~* Currently receiving noninvasive ventilation support (NIV NAVA, NIPPV, nCPAP, HFNC)~Exclusion Criteria:~* Major congenital anomalies of the heart and lungs~* Post menstrual age greater than 50 weeks 0 days~* Oxygen requirement greater than 40%

- Gender: ALL
- Minimum Age: 28 Days
- Maximum Age: 1 Year
- Healthy Volunteers: f

Study Arms:
- Alternating between Synchronized and Continuous HFNC at 6 and 8 LPM (starting with synchronized) (Type: EXPERIMENTAL): Subjects will first receive HFNC synchronized to his/her own efforts via NAVA at 6 LPM followed by continuous HFNC at 6 LPM and then HFNC synchronized to his/her own efforts via NAVA at 8 LPM followed by continuous HFNC at 8 LPM
- Alternating between Synchronized and Continuous HFNC at 6 and 8 LPM (starting with continuous) (Type: ACTIVE_COMPARATOR): Subjects will first receive continuous HFNC at 6 LPM followed by HFNC synchronized to his/her own efforts via NAVA at 6 LPM. Next, subjects will receive continuous HFNC at 8 LPM followed by HFNC synchronized to his/her own efforts via NAVA at 8 LPM.

Based on this trial design, predict the completion outcome and termination type (if applicable).